MENU
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Protalix BioTherapeutics (PLX) Earnings Date & Reports

A.I. Advisor
published Earnings

PLX is expected to report earnings to rise 233.33% to 10 cents per share on March 13

Protalix BioTherapeutics PLX Stock Earnings Reports
Q4'24
Est.
$0.10
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.04
Q4'23
Est.
$-0.03
The last earnings report on November 14 showed earnings per share of 2 cents, missing the estimate of 5 cents. With 158.68K shares outstanding, the current market capitalization sits at 103.70M.
View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com